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A c c e p t e d M a n u s c r i p t 5 al., 2004) . In a similar survey in Norway, the prevalence of CNS was 16% (Østerås et al., 2006) . 1
It is difficult to compare results from different countries because the number of colony forming 2 units (CFU) per ml that is used as cut-off to categorize samples as CNS-positive varies between 3 studies. In the Finnish survey with the high prevalence, detection of 500 CFU/ml was used to 4 classify a sample as CNS positive, whereas the cut-off value in the Norwegian survey was 4000 5 CFU/ml. Use of a high CFU/ml cut-off for diagnosis of CNS infections may contribute to 6 underreporting of CNS mastitis. 7
The proportion of CNS among bacteria isolated from clinical mastitis cases remains very 8 low in many countries. In a recent study from Canada, CNS were isolated from 6% of quarters 9
with clinical mastitis (Olde Riekerink et al., 2007) . In a Wisconsin study on milk samples from 10 clinical and subclinical mastitis obtained between 1994 and 2001 (Makovec and Ruegg, 2003) , 11 the proportion of CNS isolates increased from 12.7% to 17.5%, but separate results were not 12 provided for clinical mastitis. In Sweden, CNS comprised only 6% of bacteria isolated from 13 clinical mastitis (Ekman and Østerås, 2004) . In Switzerland, the respective figure was 17% 14 (Schällibaum, 2001) Finland, more than 20% of bacterial isolates from milk samples from clinical mastitis were CNS 19 (Nevala et al., 2004) . In a study on clinical mastitis carried out in the same area about 30 years 20 ago, the proportion of CNS was only 6.5% (Pyörälä and Syväjärvi, 1987 M a n u s c r i p t 6 In Norway, too, the highest prevalence of CNS mastitis was found during the late indoor season 1 (Østerås et al., 2006) . The proportion of CNS is generally high in samples collected from animals 2 with subclinical mastitis but low in samples from animals with clinical mastitis. In countries 3 where the biggest udder health problems are caused by major environmental mastitis pathogens, 4 CNS infections may often be ignored. 5
The prevalence of CNS mastitis is higher in primiparous cows than in older cows 6 (Matthews et al., 1992; Poelarends et al., 2001; Tenhagen et al., 2006) . CNS can colonize the 7 mammary gland of pregnant heifers (White et al., 1989; Myllys, 1995) , and CNS were isolated 8 from the mammary gland and teat apices of heifers as young as 10 months old (Boddie et al., 9 1987; De Vliegher et al., 2003) . In intensive management systems, the prevalence of quarters of 10 precalving heifers infected with CNS can exceed 50% (Trinidad et al., 1990b; Oliveira et al., 11 2006) . In pasture-based grazing systems a lower prevalence (16%) has been reported (Parker et 12 al., 2007) . Even under grazing conditions, CNS were the predominant isolates in precalving 13 heifers (77% of the bacteriologically positive quarters). 14 CNS are important pathogens in cattle of all ages, but the predominant CNS species 15 causing infection seems to differ between age groups. S. chromogenes was the major CNS 16 species in pre-calving heifers and primiparous cows (Trinidad et al., 1990b Finnish study, half of the intramammary infections due to CNS were clinical, but in the majority 6 of the cases the signs were very mild (Taponen et al., 2006) . No significant differences in the 7 severity of clinical signs caused by the two most common CNS species were found in that study, 8 which agrees with the findings of a previous study (Jarp, 1991) . CNS infection is generally seen 9
as an increase in the SCC in milk of the infected quarter. Milk SCC usually remains below 10 500,000 cells/ml (Djabri et al., 2002) . In a study in which dairy cows were followed-up 11 throughout the whole lactation, the geometric mean SCC was over 600,000 cells/ml in quarters 12 with persistent CNS infection, and about 60,000 cells/ml in healthy quarters (Taponen et al., 13 2007) . Even a transient CNS infection caused a temporary increase in milk SCC, which is 14 consistent with the report of Laevens et al. (Laevens et al., 1997) . In a study analyzing the 15 relationship between clinical mastitis and SCC patterns, a higher risk for occurrence of CNS 16 mastitis in lactations with high average SCC was found (de Haas et al., 2004). The direct 17 economical impact of high SCC depends on the violation of limits for poor quality milk or 18 possible quality premiums paid for high quality milk. These differ considerably between 19 countries. The current legal limit in the European Union (EU) is 400,000 cells/ml, but in the US it 20 is as high as 750,000 cells/ml, so increases in bulk milk SCC have a different effect in these 21 regions. Many EU countries pay quality premium for milk with less than 250,000 cells/ml 22 (International Dairy Federation, 2006) . In general, increases in milk SCC over 100,000 cells/ml 23 A c c e p t e d M a n u s c r i p t 8 are associated with reduced milk production. Elevated milk SCC theoretically results in less milk 1 per animal going into the bulk tank (Hortet and Seegers, 1998; Østerås et al., 2006) . In studies on 2 the effect of CNS intramammary infections on milk production, a slightly decreased milk 3 production has been reported (Timms and Schultz, 1987; Gröhn, 2004; De Vliegher et al., 2005) . 4
In heifers, quarters infected with "non-aureus staphylococci" exhibited leucocyte 5 infiltration and a higher percentage of interalveolar stroma as compared with healthy controls, 6
which can have deleterious effects on future milk production (Trinidad et al., 1990a) . In a Finnish 7 study, heifers with mastitis had a slightly higher genetic potential for milk production but their 8 recorded milk yield was slightly lower than that of their healthy herd mates (Myllys and Rautala, 9 1995 ). Gröhn et al. (2004) showed that multiparous cows with clinical CNS mastitis were 10 originally higher producers than their herd mates without CNS mastitis. Milk production losses 11 due to CNS mastitis could be underestimated if animals were compared with their herd mates 12 rather than with their own pre-infection production levels or genetic potential. 13 observed in groups treated with pirlimycin but the difference between groups was not statistically 18 significant. Based on review of the literature and the authors' experience, it is our opinion that 19 CNS mastitis generally responds well to antimicrobial therapy and that the customary 20 antimicrobial treatment duration of 2-3 days can be used for CNS mastitis. is the treatment of first choice, beta-lactamase production can be determined by a rapid 6 nitrocephin test to assess penicillin sensitivity of isolates (Pyörälä, 2006) . Nitrocephin tests were 7 recently shown to be sufficiently reliable to be recommended for routine clinical use to test beta-8 lactamase production of mastitis staphylococci (Pitkälä et al., 2007) . For persistent CNS 9 infections, antimicrobial treatment at drying-off remains a good tool, as cure rates of dry cow 10 therapy are generally very high for CNS infections (Newton et al., 2008) . Some CNS isolated from mastitis may be opportunists from the environment, but in the authors ' 22 opinion it is very likely that at least the main species infecting the bovine mammary gland are 23 M a n u s c r i p t 12 specifically adapted to the udder environment. Species of CNS may differ in this respect, but 1 information is lacking. In most herds, pregnant heifers are more likely to be infected with CNS 2 than cows. In solving CNS mastitis problems, focus should therefore be on the heifers, i.e. their 3 environment, feeding and management, before calving. The authors believe that welfare and 4 comfort of heifers may be significant factors for good udder health. 5
Prepartum intramammary antibiotic therapy for heifers reduced the number of CNS 6 infections during first lactation, but the effect on SCC was variable (Oliver et al., 2003; 7 Middleton et al., 2005) . In a recent study of several herds from the U.S. and Canada (Borm et al., 8 2006) , no clear advantage from this practice was demonstrated. In addition, antimicrobial 9 treatment of heifers as a routine management procedure cannot necessarily be considered as 10 prudent use of antimicrobials. In a meta-analysis on the efficacy of dry cow treatment (Robert et 11 al., 2006) , no significant benefit was established regarding the prevention of CNS infections with 12 blanket dry cow therapy. 13
Among other preventive measures against mastitis, non-antibiotic internal teat sealants 14 have come into use as an alternative or complement to antimicrobial dry cow therapy. Most 15 studies have focused on the prevention of intramammary infections caused by major pathogens, 16 and CNS have not been specifically addressed (Huxley et al., 2002; Sanford et al., 2006) . Internal 17 teat sealants have also been tested in pre-partum heifers, in which they significantly reduced the 18 risk of intramammary infections and clinical mastitis post-calving . In that 19 study, a protective effect was demonstrated against CNS infections. Another approach to protect 20 teats against infections during the dry period would be the use of external teat seals administered 21 at drying-off, before calving or at both times (Godden et al., 2006) . There is little peer-reviewed 22 evidence of the efficacy of external teat sealants, and short duration of adherence of the sealant to 23 M a n u s c r i p t 13 the teat can be a problem. In a Norwegian study, external teat sealants did not provide protection 1 
